| Literature DB >> 28446464 |
Bingqing Huang1,2, Huipeng Yang1, Xixi Cheng1, Dan Wang1, Shuyu Fu1, Wencui Shen3, Qi Zhang1, Lijuan Zhang1, Zhenyi Xue1, Yan Li1, Yurong Da1, Qing Yang4,5, Zesong Li6, Li Liu7, Liang Qiao8, Ying Kong9, Zhi Yao1, Peng Zhao10,5, Min Li11,12, Rongxin Zhang13,14.
Abstract
Several studies have shown that tRNAs can be enzymatically cleaved to generate distinct classes of tRNA-derived fragments (tRF). Here, we report that tRF/miR-1280, a 17-bp fragment derived from tRNALeu and pre-miRNA, influences Notch signaling pathways that support the function of cancer stem-like cells (CSC) in colorectal cancer progression. tRF/miR-1280 expression was decreased in human specimens of colorectal cancer. Ectopic expression of tRF/miR-1280 reduced cell proliferation and colony formation, whereas its suppression reversed these effects. Mechanistic investigations implicated the Notch ligand JAG2 as a direct target of tRF/miR-1280 binding through which it reduced tumor formation and metastasis. Notably, tRF/miR-1280-mediated inactivation of Notch signaling suppressed CSC phenotypes, including by direct transcriptional repression of the Gata1/3 and miR-200b genes. These results were consistent with findings of decreased levels of miR-200b and elevated levels of JAG2, Gata1, Gata3, Zeb1, and Suz12 in colorectal cancer tissue specimens. Taken together, our results established that tRF/miR-1280 suppresses colorectal cancer growth and metastasis by repressing Notch signaling pathways that support CSC phenotypes. Furthermore, they provide evidence that functionally active miRNA can be derived from tRNA, offering potential biomarker and therapeutic uses. Cancer Res; 77(12); 3194-206. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28446464 DOI: 10.1158/0008-5472.CAN-16-3146
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701